Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis

Ulcerative colitis (UC), a relapsing-remitting chronic inflammatory bowel disease (IBD), has a variable natural course but potentially severe disease course. Since the development of anti-tumor necrosis factor (TNF) agents has changed the natural disease course of moderate-to-severe UC, therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Soo-Young, Choi, Chang Hwan, Song, Eun Mi, Bang, Ki Bae, Park, Sang Hyoung, Kim, Eun Soo, Park, Jae Jun, Keum, Bora, Lee, Chang Kyun, Lee, Bo-In, Ryoo, Seung-Bum, Koh, Seong-Joon, Choi, Miyoung, Kim, Joo Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911265/
https://www.ncbi.nlm.nih.gov/pubmed/35645321
http://dx.doi.org/10.5217/ir.2022.00007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911265/
https://www.ncbi.nlm.nih.gov/pubmed/35645321
http://dx.doi.org/10.5217/ir.2022.00007

Ejemplares similares